Maybe I'm late to the party?

[nightster]

Maybe I'm late to the party, but has anyone watched this video

?
It seems interesting. I'm not sure Im sold on it, but I figured there are people here who are much smarter than I who may be aware or have input on this.

 

[genetic freak]

If you look into the clinical studies used on these drugs the results were similar to you starting TRT for the first time. However, the price tag would be somewhere around 1.25-1.5 million per quarter.

 

[nightster]

If you look into the clinical studies used on these drugs the results were similar to you starting TRT for the first time. However, the price tag would be somewhere around 1.25-1.5 million per quarter.

I think maybe hard work and a.a.s. Will have to be fine for me for awhile... lol

 

[rawdeal]

I think maybe hard work and a.a.s. Will have to be fine for me for awhile... lol

Those got a lot of people where they are today, and many of them are here today. Stick around, many of them like to help .

 

[jipped genes]

If you look into the clinical studies used on these drugs the results were similar to you starting TRT for the first time. However, the price tag would be somewhere around 1.25-1.5 million per quarter.

As soon as it hits the UG market it will be $200 a vial that lasts 6 weeks.

 

[Wilson6]

Myostatin regulates more than just muscle mass and there is so much we don't know about it inhibiting it. Wouldn't touch that stuff at this time. I'd like to see in particular, cardiac data (function and structure) in humans on a myostatin inhibitors. Going beyond myostatin inhibitors is pure science fiction at this point. I'll stick with TRT and low dose GH.

 

[mdmusclemachine]

I am in agreement with WILSON6 here. I also looked up the potential cost, and it tens ofthousand from a legit American research site.

 

[two_slug]

Anybody remember back in the early 2000's and how they said SARM's would make AAS obsolete. Well, we see how that worked out.

 

[Heady Muscle]

https://investor.regeneron.com/news-releases/news-release-details/results-phase-2-courage-trial-demonstrating-potential-improve/#:~:text=During%20the%20weight%2Dloss%20phase%2C%20patients%20were%20randomized,analysis%20from%20baseline%20to%20week%2026%20include: